March 27, 2017 7:39 PM ET


Company Overview of GammaCan International Inc.

Company Overview

GammaCan International Inc. develops proprietary immunotherapy for the treatment of melanoma and other cancers. Its patented platform technology is based on the use of IgGs (gamma-immunoglobulins), a relatively non-toxic human plasma-derived product used to treat various immune deficiencies and autoimmune diseases. The company's lead drug candidate, VitiGam, targets stage III and stage IV melanoma. VitiGam received Orphan Drug designation from the U.S. Food and Drug Administration for the treatment of Stage IIB to Stage IV metastatic melanoma. GammaCan International Inc. has a research and licensing agreement with Tel Hashomer Medical Research Infrastructure and Services, Ltd. to conduct a r...

Kiryat Ono Mall

Azorim Center A

39 Jerusalem St.

Kiryat Ono,  55423


Founded in 1998

8 Employees


972 3 738 2616


972 3 635 6015

Key Executives for GammaCan International Inc.

Chief Financial Officer, Treasurer and Director
Age: 46
Chief Scientist of Gammacan Ltd
Age: 68
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
3PLW Ltd. Middle East/Africa
Accelerated Evolution Biotechnologies Ltd Middle East/Africa
Adante Ltd. Middle East/Africa
Advanced Biotechnology Ltd. Middle East/Africa
Advanced Medical Analysis (AMA) Ltd. Middle East/Africa

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GammaCan International Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at